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2It seems rather remarkable that an off-hand observation made
ecades ago on the existence of circular RNA molecules, is in-
reasingly capturing investigators’ interests [1] . In this article in
BioMedicine , Zhang and colleagues turned their attention to the
ffect of a well-known and frequently described circular RNA (cir-
RNA) derived from the HIPK3 gene (circHIPK3) on oxaliplatin-
esistance in colorectal cancer [2] . 
CircRNAs are formed by splicing the 3 ′ end of an exon to the 5 ′ 
nd of its own or an upstream exon, generating a single stranded,
ircular molecule. Initially, circRNAs were considered to be idiosyn-
rasies of the splicing machinery and to comprise only a small
raction of the transcriptome, its obscurity at the time enhanced by
he unknown functionality. As nicely reviewed in 2016 by Barrett &
alzman, modern RNA sequencing methods revealed that circRNAs
re actually highly abundant isoforms present for thousands of hu-
an genes, they exhibit cell type-speciﬁc expression and are con-
erved between mouse and human [3] . The ﬁnding that circCDR1
epresents a highly effective sponge for a tumor-suppressive mi-
roRNA (miRNA; miR-7) raised the interest of the cancer research
eld and resulted in numerous additional studies hunting for cir-
RNAs able to bind miRNAs as well as for circRNAs with other reg-
latory functions [4] . 
In the ﬁrst months of this year, three transcriptome-wide stud-
es were published describing a large compendium of circRNAs
resent in large numbers of patients: 20 0 0 + pan-cancer cases [5] ,
48 breast cancer cases [6] and 144 prostate cancer cases [7] , with
ll studies reporting the presence and involvement of thousands
f circRNAs. Other highlights from these studies include the obser-
ations that selected circRNAs exert functional relevance in breast
nd prostate cancer cell lines that is independent from the func-
ion of their linear counterpart and that circRNAs are detectable
n patients’ blood. circHIPK3 represents one of the relatively well
tudied circRNAs, which is abundantly expressed in a variety of∗ Corresponding author. 
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rowth. In particular, this circRNA was found to sponge a number
f different miRNAs [8] . Subsequent studies showed this miRNA
ponging capacity to be relevant in many human malignancies,
ncluding colorectal cancer (CRC). Zeng et al. already found that
igh-level expression of circHIPK3 was an independent prognos-
ic factor of poor overall survival (OS) in CRC [9] and that this
as associated with miR-7 sponging in vitro . In the article by
hang et al., they convincingly show that circHIPK3 is involved
n oxaliplatin-resistance in CRC [2] . In summary, they found 1)
ncreased expression of circHIPK3 in oxaliplatin-resistant CRC pa-
ients and cell lines, 2) a larger tumor size in circHIPK3 overex-
ressing xenograft mice models upon oxaliplatin-treatment and 3)
hat high circHIPK3 levels were predictive for recurrence and poor
urvival in oxaliplatin-platin treated CRC-patients. Mechanistically,
his inhibition was found to be the result of miR-637 sponging
nd subsequent increase in STAT3 expression ultimately resulting
n autophagy inhibition. Interestingly, a role for circHIPK3 in au-
ophagy regulation was already described in lung cancer via spong-
ng of miR-124–3p, further underlining its potential role as a key
utophagy regulator [10] . 
Taken together, although there is ample evidence for the rele-
ance of circRNAs in both healthy and diseased cells, we are only
eginning to understand their biogenesis and functional roles. Next
o their documented function as miRNA sponge, circRNAs have for
nstance been described to regulate splicing and transcription, as
ell as interact with RNA-binding proteins (RBPs). The fact that cir-
RNAs lack a free 5 ′ or 3 ′ end renders them extremely stable com-
ared to their linear counterparts, which greatly increases their
otential as minimally invasively detectable biomarkers as exem-
liﬁed by their recent detection in among others exosomes, saliva,
lasma and urine. Above described studies already implicate the
otential value of circRNAs as prognostic and/or predictive mark-
rs in oncology. On the other hand, even though thousands of cir-
RNAs can be detected in cancer, a potential showstopper for cir-RNAs as biomarker for cancer detection could be the observation 
nder the CC BY-NC-ND license. ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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 that, in general, circRNAS appear lower expressed in cancer cells
compared to healthy cells. 
With the recent availability of the large catalogues of detectable
circRNAs in cancer, we have come a long way from the ‘rabbit ears’
and ‘pan-handles’ that were seen by Hsu and Coca-Prados in 1979
in their electron micrographs. It will be intriguing to see whether
in future studies circRNAs will be able to redeem their clinical
promise as biomarker, therapeutic target and potentially even as
therapeutic vehicle. 
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